208 related articles for article (PubMed ID: 6846376)
1. Relationship of lipid disorders to coronary heart disease.
Glueck CJ
Am J Med; 1983 May; 74(5A):10-4. PubMed ID: 6846376
[TBL] [Abstract][Full Text] [Related]
2. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
3. The emerging problem of plasma lipid changes during antihypertensive therapy.
Johnson BF
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
[TBL] [Abstract][Full Text] [Related]
4. [High-density lipoproteins in children with coronary diseases].
Oberhänsli I; Pometta D; Micheli H; Raymond L
Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385
[TBL] [Abstract][Full Text] [Related]
5. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
Athyros VG; Papageorgiou AA; Avramidis MJ; Kontopoulos AG
Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
[TBL] [Abstract][Full Text] [Related]
7. [Various lipoprotein fractions and their relation to ischemic heart disease].
Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
[TBL] [Abstract][Full Text] [Related]
8. Lipid measurements for coronary risk assessment: a review.
Berg LH
Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
[TBL] [Abstract][Full Text] [Related]
9. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
10. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
11. European and American recommendations for coronary heart disease prevention.
Wood D
Eur Heart J; 1998 Feb; 19 Suppl A():A12-9. PubMed ID: 9519337
[TBL] [Abstract][Full Text] [Related]
12. [Risk factor hyperlipidemia. Dealing with reality].
Wolfram G
MMW Munch Med Wochenschr; 1982 Feb; 124(5):91-2. PubMed ID: 6806637
[No Abstract] [Full Text] [Related]
13. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
14. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
[TBL] [Abstract][Full Text] [Related]
15. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
16. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
17. [Changes in serum lipid levels, lipid composition and lipoprotein fractions in patients with ischemic cardiopathies or arterial hypertension].
Dakovska L; Orbetzov M; Orbetzova V; Yarovska N
Paroi Arterielle; 1981; 7(1):15-22. PubMed ID: 7339537
[TBL] [Abstract][Full Text] [Related]
18. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
19. Lipid and lipoprotein tracking in 108 children over a four-year period.
Laskarzewski P; Morrison JA; deGroot I; Kelly KA; Mellies MJ; Khoury P; Glueck CJ
Pediatrics; 1979 Nov; 64(5):584-91. PubMed ID: 226923
[No Abstract] [Full Text] [Related]
20. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
